drugset / Trial / NCT00215449
Study in Patients With COPD
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the efficacy and safety of the investigational drug in the treatment of COPD in comparison with a placebo.
Timeline
- Start
- —
- Primary completion
- 2005-12
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Formoterol | Other / unclassified | 12 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 20 ug | Inhaled |